• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERPORT MRI 8GS, INT. W SP, ATT S/L; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERPORT MRI 8GS, INT. W SP, ATT S/L; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number 1878000
Medical Device Problem Codes Fracture (1260); Material Separation (1562); Migration (4003)
Health Effect - Clinical Codes Chest Pain (1776); Tachycardia (2095); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/29/2023
Type of Reportable Event Death
Additional Manufacturer Narrative
H10: as the lot number for the device was not provided, a review of the device history records could not be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported through the litigation process that sometime post a port placement, the catheter had allegedly fractured.There was no reported patient injury.
 
Event or Problem Description
It was reported through litigation process that approximately five days later post port placement procedure for chemotherapy treatment, the port catheter allegedly fractured and migrated into the right heart.It was further reported that patient developed with chest pain and low back pain due to broken catheter and that was removed by snare.Reportedly, the port was removed and new port has been implanted.However, the patient was expired and the cause of death was not provided.
 
Additional Manufacturer Narrative
H10: additional information was received, and the file was reassessed for reportability and determined to be reportable as death.H10: date of death for this patient was not provided, date of death updated as (b)(6)1900 for the mdr submission requirement.H10: as the lot number for the device was provided, a review of the device history records will be performed.The device has not been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.H10: d4 (expiration date: 12/2025), g2, g3, h6 (device).H11: b2, b3, b5, d4 (medical device lot number), h1, h6 (patient, result, conclusion).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Additional Manufacturer Narrative
H10: date of death for this patient was not provided, date of death updated as 01-jan-1900 for the mdr submission requirement.H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the physical device was not returned for evaluation.Medical records were provided and reviewed.Approximately six days post port placement, the medical record describes the catheter of the port breaking completely sometime after insertion and the distal portion of it migrating into the right heart.These events are therefore confirmed.The back pain and patient death are not described in the medical record and therefore cannot be confirmed.The medical record also describes tachycardia, which can therefore also be confirmed.The catheter segment and port body were then removed and replaced.No relationship between the expiration of the patient and the port has been confirmed.A definitive root cause could not be determined based upon the available information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H10: b5, g3, h6 (patient, method).H11: d4 (unique identifier (udi) #), h6 (result, conclusion).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported through litigation process that approximately five days post a port placement for chemotherapy treatment, the port catheter allegedly fractured and migrated into the right heart.It was further reported that the patient developed with chest pain, low back pain and ventricular tachycardia due to broken catheter and that was removed by snare.Reportedly, the port was removed and new port has been implanted.However, the patient was expired and the cause of death was not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPORT MRI 8GS, INT. W SP, ATT S/L
Common Device Name
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key19689031
Report Number3006260740-2024-03532
Device Sequence Number8122869
Product Code LJT
UDI-Device Identifier00801741027246
UDI-Public(01)00801741027246(11)230311(17)251231(10)REHN2490
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K063377
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2023
Reporter Type Manufacturer
Report Source Other,Consumer,Health Professional
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 11/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/31/2025
Device Catalogue Number1878000
Device Lot NumberREHN2490
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/11/2024
Supplement Date Received by Manufacturer07/24/2024
12/05/2024
Initial Report FDA Received Date07/08/2024
Supplement Report FDA Received Date08/22/2024
12/11/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/11/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Death;
Patient Age54 YR
Patient SexFemale
-
-